Expression of androgen receptor splice variants in clinical breast cancers.
about
Androgen Receptor: A Complex Therapeutic Target for Breast CancerBreast cancer molecular subtypes: from TNBC to QNBCTruncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer.Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin.Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma.AR-Signaling in Human Malignancies: Prostate Cancer and Beyond.Novel Nine-Exon AR Transcripts (Exon 1/Exon 1b/Exons 2-8) in Normal and Cancerous Breast and Prostate Cells.Steroid hormone receptors as prognostic markers in breast cancer.Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.Family Matters: Collaboration and Conflict Among the Steroid Receptors Raises a Need for Group Therapy.Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer.Snail promotes resistance to enzalutamide through regulation of androgen receptor activity in prostate cancer.Targeting the androgen receptor in triple-negative breast cancer: current perspectives.Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer.AR Expression in Breast Cancer CTCs Associates with Bone Metastases.Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate Cancer.
P2860
Q28075188-AE416BD3-E248-49F3-ADDF-ABF18C62810CQ28076805-A1886B4E-D4A2-4CCE-90AC-ECEE320D8179Q30831010-2D57C443-9BF7-4B55-BDFF-9746753F9C63Q33728381-1E09514F-A446-4CD6-B9C1-46D35CDEE673Q37269053-EF4C7353-D0E7-4CD6-A4EE-CFFC64D0288FQ37392841-B339C789-247B-4BEC-AB07-D7B060A93E5FQ37629545-59F783C1-1F54-4CFC-8C0A-2447766B7CCBQ37631437-98EF07A8-74AE-4345-8E28-496E343B3821Q38598704-62E1EBC0-FB5C-4559-BD64-0F1FE73701E7Q38943216-485B77EC-99CE-4977-8CBF-AD0462DC6ED9Q39005392-DE9E16CE-1A8A-4F7B-B856-694E178DF0ABQ39016544-F49780AA-87D1-47B5-9BE4-932BD01FF8A4Q41270542-510A6626-0974-485F-A7B2-C8E484228E5CQ42364449-BD511656-2E31-42E3-9CDC-3CA140CC4D61Q48229904-B93C5E09-15AF-4F07-8BD3-5BA174A2C72DQ49913672-D940CE00-2D22-4128-A3E4-52A29017883EQ51019461-246ED3ED-789C-4230-B160-2C1684EE4C88
P2860
Expression of androgen receptor splice variants in clinical breast cancers.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Expression of androgen receptor splice variants in clinical breast cancers.
@ast
Expression of androgen receptor splice variants in clinical breast cancers.
@en
type
label
Expression of androgen receptor splice variants in clinical breast cancers.
@ast
Expression of androgen receptor splice variants in clinical breast cancers.
@en
prefLabel
Expression of androgen receptor splice variants in clinical breast cancers.
@ast
Expression of androgen receptor splice variants in clinical breast cancers.
@en
P2093
P2860
P50
P356
P1433
P1476
Expression of androgen receptor splice variants in clinical breast cancers
@en
P2093
Adrienne R Hanson
Connie M Irvine
Dong Gui Hu
Ganesh V Raj
Marie A Pickering
Natalie K Ryan
Roslin Russell
Scott M Dehm
Stephen N Birrell
Stephen R Plymate
P2860
P304
44728-44744
P356
10.18632/ONCOTARGET.6296
P407
P50
P577
2015-12-01T00:00:00Z